Tempus Signs Strategic Collaboration Agreement With AstraZeneca to Advance Oncology Therapeutics
CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced a multi-year, strategic collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) in which the two companies will work together to gather...